These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 34578147)
1. Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein-Barr Virus Infection. Peng X; Zhou Y; Tao Y; Liu S Pathogens; 2021 Aug; 10(9):. PubMed ID: 34578147 [TBL] [Abstract][Full Text] [Related]
2. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma. Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line. Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743 [TBL] [Abstract][Full Text] [Related]
4. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression. Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254 [TBL] [Abstract][Full Text] [Related]
5. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma. Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748 [TBL] [Abstract][Full Text] [Related]
6. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells. Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068 [TBL] [Abstract][Full Text] [Related]
7. Targeting Exosomal EBV-LMP1 Transfer and miR-203 Expression via the NF-κB Pathway: The Therapeutic Role of Aspirin in NPC. Zuo L; Xie Y; Tang J; Xin S; Liu L; Zhang S; Yan Q; Zhu F; Lu J Mol Ther Nucleic Acids; 2019 Sep; 17():175-184. PubMed ID: 31265948 [TBL] [Abstract][Full Text] [Related]
8. CD47 Overexpression Is Associated with Epstein-Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma. Wang ZH; Pei XF; Zhu ZQ; Lin Z; Mao YY; Xu XL; Luo YL; Zhang L; Peng PJ Onco Targets Ther; 2020; 13():3325-3334. PubMed ID: 32368091 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells. Lo AK; Lo KW; Ko CW; Young LS; Dawson CW J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276 [TBL] [Abstract][Full Text] [Related]
10. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion. Ho CH; Chen CL; Li WY; Chen CJ Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191 [TBL] [Abstract][Full Text] [Related]
11. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression. Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217 [TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. Miller WE; Earp HS; Raab-Traub N J Virol; 1995 Jul; 69(7):4390-8. PubMed ID: 7769701 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways. Zhang J; Jia L; Lin W; Yip YL; Lo KW; Lau VMY; Zhu D; Tsang CM; Zhou Y; Deng W; Lung HL; Lung ML; Cheung LM; Tsao SW J Virol; 2017 Mar; 91(6):. PubMed ID: 28053105 [TBL] [Abstract][Full Text] [Related]
14. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study. Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815 [TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth. Huo H; Hu G Infect Agent Cancer; 2019; 14():30. PubMed ID: 31673282 [TBL] [Abstract][Full Text] [Related]
16. Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. Zheng X; Hu L; Chen F; Christensson B Eur J Cancer B Oral Oncol; 1994 Sep; 30B(5):290-5. PubMed ID: 7703798 [TBL] [Abstract][Full Text] [Related]
17. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells. Wasil LR; Wei L; Chang C; Lan L; Shair KH J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552 [TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection and nasopharyngeal carcinoma. Tsao SW; Tsang CM; Lo KW Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937 [TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]